Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,413.83 -11.02 -0.07%
S&P 500 1,866.12 3.81 0.20%
NASDAQ 4,096.72 10.50 0.26%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Alkermes’ Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference



  Alkermes’ Corporate Presentation to be Webcast at the Bank of America
  Merrill Lynch 2013 Smid Cap Conference

Business Wire

DUBLIN -- May 01, 2013

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Bank of America Merrill Lynch 2013 Smid Cap
Conference on Wednesday, May 8, 2013, at 9:30 a.m. EDT (2:30 p.m. BST) from
the Four Seasons Hotel in Boston. The presentation may be accessed under the
Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that
applies its scientific expertise and proprietary technologies to develop
innovative medicines that improve patient outcomes. The company has a
diversified portfolio of more than 20 commercial drug products and a
substantial clinical pipeline of product candidates that address central
nervous system (CNS) disorders such as addiction, schizophrenia and
depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center
in Waltham, Massachusetts; a research and manufacturing facility in Athlone,
Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington,
Ohio. For more information, please visit Alkermes’ website at
www.alkermes.com.

Contact:

Alkermes plc
Eva Stroynowski, +1 781 609 6823
Corporate Communications
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement